Qian Cao

Director/Board Member at NINGBO MENOVO PHARMACEUTICAL CO., LTD.

Net worth: 508 146 $ as of 2024-03-30

42 year

Health Technology

Profile

Qian Cao has worked as a Director at Zhejiang Liaoyuan Pharmaceutical Co., Ltd.
since 2015 and at Ningbo Menovo Pharmaceutical Co., Ltd.
since 2018.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NINGBO MENOVO PHARMACEUTICAL CO., LTD. CLASS A 0.09%	2023-03-18	192,103 ( 0.09% )	372 647 $	2024-03-30
NINGBO MENOVO PHARMACEUTICAL CO. LTD. 3.11%	2023-03-18	69,851 ( 3.11% )	135 499 $	2024-03-30

Qian Cao active positions

Companies	Position	Start
NINGBO MENOVO PHARMACEUTICAL CO., LTD.	Director/Board Member	2018-06-19
Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.	Director/Board Member	2015-04-24

All active positions of Qian Cao

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Qian Cao's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NINGBO MENOVO PHARMACEUTICAL CO., LTD.	Health Technology

Private companies	1
Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.	Health Technology